home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

NetZealous LLC DBA GlobalCompliancePanel

 
  February 28, 2018  
     
 
NetZealous LLC DBA GlobalCompliancePanel, SFO, CA
2018-04-09


Course "ISPE GAMP Guide: Records and Data Integrity" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.

Overview:

The impact of Data Integrity issues on a regulated company can be significant: it can result in recalls of products, warning or untitled letters, import alerts, injunctions, seizures, legal action, etc. These regulatory actions can have significant financial impact to the company. However, and most importantly, data integrity issues can lead to potential patient harm!!

Defined by the Medicines and Healthcare Products Regulatory Agency (MHRA) as "the extent which all data are complete, consistent and accurate throughout the data lifecycle", data integrity is increasingly the focus of regulatory agencies round the world. Companies must now ensure that they are appropriately addressing data integrity and data governance. This includes organizational, procedural and technical controls that must be considered as part of an overarching data governance system. In addition, the effort and resources committed to data integrity must be commensurate with the role it plays in assuring product quality.

To ensure Data Integrity, a GxP regulated company needs to abide by principles, current regulations and industry best practices on the expectations for the management GxP regulated records and data. These principles, regulations and best practices, ensure that data is complete, consistent, accurate, secure and available throughout the record life cycle. This approach is intended to encourage innovation and technological advances while avoiding unacceptable risk to product quality, patient safety and public health.

Key implementation considerations for a corporate data integrity program, include development of a high-level strategy, identifying and gaining executive sponsorship, focusing on management accountability, implementing tools for knowledge sharing and developing and providing the appropriate levels of training. An effective data integrity program includes addressing of behavioral factors and drives a strategy that focuses on prevention, detection, response and continuous improvement.

The Seminar

This Seminar addresses the integrity of GxP records and data used within the regulated industries including pharmaceutical, biological, medical devices, cosmetics, food and any other industry where data integrity is important. It provides a method for managing risk to record and data integrity. Learning Objectives for the seminar include:

  1. Data Integrity Requirements
  2. Critical Areas of Regulatory Focus and Concern
  3. Key Concepts
  4. A Framework for Data Governance and Human Factors
  5. A Complete Data Life Cycle Approach as Part of a Quality Management System, from Creation to Destruction
  6. How to Apply Risk Management to Data Integrity

Why you should attend:

  • VP of IT
  • Director of IT
  • Quality Managers
  • Project Managers (for CSV / IT)
  • Validation Specialists
  • Database Administrators
  • System Administrators
  • Directors / Senior Directors of Discovery
  • Directors / Senior Directors of Development
  • Directors / Senior Directors of Commercialization
  • Document Managers
  • Training Managers
  • Regulators
  • Vendors
  • Suppliers
  • Outsource Service Providers

Industries

  • Pharmaceuticals
  • Biotech
  • Medical Device
  • Radiological Health
  • Blood Products
  • Companion Animals
  • Food
  • Cosmetics
  • Tobacco
  • Academia

Agenda:

Day 1 Schedule

Lecture 1: Introduction and Background

  • Introductions / Participants' Understanding / Participants' Objectives for the Course (Please come prepared to discuss)
  • Regulatory Focus
  • Data Integrity Requirements

Lecture 2: Data Governance Framework

  • Elements of the Data Governance Framework
  • Human Factors in Data Integrity
  • Data Integrity Maturity Model

Lecture 3: Quality Risk Management

  • Process Risk Management
  • Quality Risk Management
  • Product and Process Context

Lecture 4: Data Life Cycle

  • Data Creation
  • Data Processing
  • Data Review, Reporting and Use
  • Data Retention & Retrieval
  • Data Destruction
  • Integrating Data Integrity into Existing Records Management Process

Day 2 Schedule

Lecture 1: Data Integrity Management

  • Corporate Data Integrity Program
  • Data Integrity Maturity Model
  • Human Factors
  • Inspection Readiness

Lecture 2: Auditing & Audit Trails

  • Data Audit Trail
  • Audit Trail Review
  • Data Auditing
  • Periodic Review

Lecture 3: Data Integrity for Electronic Records / Electronic Signatures (ERES)

  • User Requirements
  • Process Mapping & Interfaces
  • Controls for Electronic Records / Electronic Signatures
  • Data Integrity for Spreadsheets & End-User Applications
  • Data Integrity for IT Infrastructure

Lecture 4: Data Conversions

  • Retention, Archiving & Migration
  • Paper Records & Hybrid Situations
  • Converting Electronic to Alternative Format or Alternative Format Hybrids

Quiz: Jeopardy!!!!

  • Data Integrity

Speaker

Angela Bazigos

CEO, Touchstone Technologies Silicon Valley 

Angela Bazigos is the CEO of Touchstone Technologies Inc. She has 40 years of experience in the Life Sciences & Healthcare Industries. Experience combines Quality Assurance, Regulatory Compliance, Information Technology, Project Management, Clinical Lab Science, Microbiology, Food Safety and Turnarounds. Past employers / clients include Roche, Novartis, Genentech & PriceWaterhouseCoopers, Public Health Service. Positions include Chief Compliance Officer, http://morflearning.com/angelabazigos/, QA Director, Director of MIS. Co-authored & prototyped 21 CFR 11 guidance with FDA. Co-authored Computerized Systems in Clinical Research w/ FDA http://www1.diahome.org/~/media/4FA562336EBD46C58CDC43A8B7773095.ashx. Patent on speeding up software compliance https://www.google.com/patents/US8266578. Recently quoted in Wall Street Journal for using training to bring regulatory compliance to the Boardroom http://blogs.wsj.com/riskandcompliance/2015/07/24/using-training-to-bring-compliance-to-boardrooms/. Comments / collaborates with FDA on new guidance documents. Former President of Pacific Regional Chapter of Society of Quality Assurance. Stanford's Who's Who for LifeSciences: http://www.stanfordwhoswho.com/Angela.Bazigos.7144112.html#overview.

Location:  Seattle, WA

Date: April 9th & 10th, 2018

Time: 9:00 AM to 6:00 PM

Venue:  WILL BE ANNOUNCED SOON

Price:

Price: $1,995.00 (Seminar Fee for One Delegate)

 Register for 5 attendees Price: $5,985.00 $9,975.00 You Save: $3,990.00 (40%)*

Register for 10 attendees Price: $10,972.00 $19,950.00 You Save: $8,978.00 (45%)*

Register now and save $200. (Early Bird)

Until March 20, Early Bird Price: $1,995.00 From March 21 to April 07, Regular Price: $2,195.00

 

Sponsorship Program benefits for “Quality Assurance Auditing for FDA Regulated Industry” seminar

At this seminar, world-renowned FDA Regulated Industry subject matter experts interact with CXO’s of various designations. Executives who carry vast experience about FDA Regulated Industry and Experts get down to discussing industry-related best practices, regulatory updates, changes in technologies, and much more relating to FDA Regulated Industry.

As a sponsor of these seminars, you get the opportunity to have your product and company reach out to C-Level executives in FDA Regulatory -related industries and become known among these elite executives and subject matter experts. Apart from being seen prominently at these globally held seminars, you also get talked about frequently in our correspondences with our experts and these participants.

For More Information- https://www.globalcompliancepanel.com/control/sponsorship 

Contact us today!

NetZealous LLC DBA GlobalCompliancePanel

john.robinson@globalcompliancepanel.com  

support@globalcompliancepanel.com 

Toll free: +1-800-447-9407

Phone: +1-510-584-9661

 Website: http://www.globalcompliancepanel.com

 

Registration Link - Registration Link - https://www.globalcompliancepanel.com/control/globalseminars/~product_id=901684SEMINAR?april-seo-2018

Follow us on LinkedIn: https://www.linkedin.com/company/globalcompliancepanel/

Like us our Facebook page: https://www.facebook.com/TrainingsAtGlobalCompliancePanel/

Follow us on Twitter: https://twitter.com/GCPanel

 

 
 
Organized by: GlobalCompliancePanel
Invited Speakers:

Angela Bazigos

CEO, Touchstone Technologies Silicon Valley 

Angela Bazigos is the CEO of Touchstone Technologies Inc. She has 40 years of experience in the Life Sciences & Healthcare Industries. Experience combines Quality Assurance, Regulatory Compliance, Information Technology, Project Management, Clinical Lab Science, Microbiology, Food Safety and Turnarounds. Past employers / clients include Roche, Novartis, Genentech & PriceWaterhouseCoopers, Public Health Service. Positions include Chief Compliance Officer, http://morflearning.com/angelabazigos/, QA Director, Director of MIS. Co-authored & prototyped 21 CFR 11 guidance with FDA. Co-authored Computerized Systems in Clinical Research w/ FDA http://www1.diahome.org/~/media/4FA562336EBD46C58CDC43A8B7773095.ashx. Patent on speeding up software compliance https://www.google.com/patents/US8266578. Recently quoted in Wall Street Journal for using training to bring regulatory compliance to the Boardroom http://blogs.wsj.com/riskandcompliance/2015/07/24/using-training-to-bring-compliance-to-boardrooms/. Comments / collaborates with FDA on new guidance documents. Former President of Pacific Regional Chapter of Society of Quality Assurance. Stanford's Who's Who for LifeSciences: http://www.stanfordwhoswho.com/Angela.Bazigos.7144112.html#overview.

 
Deadline for Abstracts: 2018-04-08
 
Registration: https://www.globalcompliancepanel.com/control/globalseminars/~product_id=901684SEMINAR?april-2018-seo-hum-molgen
E-mail: support@globalcompliancepanel.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.